Products - Business To Business

Disclaimer: Availability of products is subject to patent restrictions in countries where applicable patents are in effect.

Download PDF
Product Name Strength and Dosage form Brand/Innovator Indication Dossier Availability
DASATINIB 20mg, 50mg, 70mg, 80mg, 100mg, 140mg Film-coated tablets Sprycel® (Bristol-Myers) Leukemia YES
VENETOCLAX 10mg, 50mg, 100mg Film-coated tablets Venclyxto® (Abbvie) Leukemia Q4-2026
METHOTREXATE 2.5 mg Film-coated tablets Novatrex® (Pfizer) Leukemia, non-Hodgkin's lymphoma YES
IBRUTINIB 140mg, 280mg, 420mg & 560mg Film-coated tablets Imbruvica® (Janssen) Lymphoma, Leukemia Q2-2026
IMATINIB 100mg, 400mg Film-coated tablets Glivec® (Novartis) Lymphoma, Leukemia YES
NILOTINIB 50mg, 150mg and 200mg Capsules, hard Tasigna® (Novartis) Lymphoma, Leukemia Q2-2025
ERLOTINIB 25mg, 50mg, 100mg, 150mg Film-coated tablets Tarceva® (Roche) Non-small cell lung cancer YES
GEFITINIB 250mg Film-coated tablets Iressa® (AstraZeneca) Non-small cell lung cancer YES
ABIRATERONE ACETATE 250mg and 500mg Film-coated tablets Zytiga® (Janssen) Prostate cancer YES
APALUTAMIDE 60mg Film-coated tablets Erleada® (Janssen) Prostate cancer Q1-2027